Literature DB >> 19031179

Morphological assessment of the interface between tumor and neighboring tissues, by magnetic resonance imaging, before and after radiotherapy in patients with locally advanced rectal cancer.

M R Torkzad1, C Suzuki, S Tanaka, G Palmer, T Holm, L Blomqvist.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI) in rectal cancer is sometimes performed after radiotherapy (MRI 2) to evaluate tumor response and to choose alternative forms of surgery. The accuracy of MRI 2 in distinguishing tumor delineation might be difficult due to fibrosis.
PURPOSE: To evaluate the morphological changes in the interface between the tumor and neighboring organs on MRI 2 performed after radiotherapy, and to assess the accuracies of MRI before and after radiotherapy compared to histopathology after surgery.
MATERIAL AND METHODS: Sixteen patients with locally advanced primary rectal cancer, with MRI before and after radiotherapy, were retrospectively studied, concerning the interface between the tumor and neighboring structures. The accuracies of MRI before and after radiotherapy were compared based on histopathology as a reference.
RESULTS: The accuracies of both MRI before and after radiotherapy were moderate, with no additional value of MRI after radiotherapy compared to MRI before radiotherapy. The most predictive form of interface for involvement of a neighboring organ after radiotherapy was nodular growth of the tumor into a neighboring structure.
CONCLUSION: The morphological assessment of pelvic MRI after preoperative radiotherapy does not provide any significant new information about tumor extent in patients with locally advanced rectal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19031179     DOI: 10.1080/02841850802477916

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer?

Authors:  Lian-Ming Wu; Jiong Zhu; Jiani Hu; Yan Yin; Hai-Yan Gu; Jia Hua; Jie Chen; Jian-Rong Xu
Journal:  Int J Colorectal Dis       Date:  2013-03-21       Impact factor: 2.571

Review 2.  Magnetic resonance imaging in rectal cancer: a surgeon's perspective.

Authors:  Avanish P Saklani; Sung Uk Bae; Amy Clayton; Nam Kyu Kim
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

3.  Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.

Authors:  Regina G H Beets-Tan; Doenja M J Lambregts; Monique Maas; Shandra Bipat; Brunella Barbaro; Filipe Caseiro-Alves; Luís Curvo-Semedo; Helen M Fenlon; Marc J Gollub; Sofia Gourtsoyianni; Steve Halligan; Christine Hoeffel; Seung Ho Kim; Andrea Laghi; Andrea Maier; Søren R Rafaelsen; Jaap Stoker; Stuart A Taylor; Michael R Torkzad; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2013-06-07       Impact factor: 5.315

4.  Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review.

Authors:  Michael R Torkzad; Lars Påhlman; Bengt Glimelius
Journal:  Insights Imaging       Date:  2010-08-15

5.  Quantitative Aspects of Diffusion-weighted Magnetic Resonance Imaging in Rectal Cancer Response to Neoadjuvant Therapy.

Authors:  Thiago Bassaneze; José Eduardo Gonçalves; Juliano Ferreira Faria; Rogério Tadeu Palma; Jaques Waisberg
Journal:  Radiol Oncol       Date:  2017-06-25       Impact factor: 2.991

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.